Retatrutide Phase 3 (TRANSCEND‑T2D‑1) cut A1C up to 2.0% and body weight up to 16.8% after 40 weeks
Eli Lilly’s investigational triple agonist retatrutide produced large reductions in both A1C and body weight in TRANSCEND‑T2D‑1, a 537‑person Phase…
“Why Standing Exercises May Outperform Weight Training for Love Handles”
Understanding Love Handles and Their Causes The traditional approach to tackling love handles is undergoing a significant transformation, particularly for…
CagriSema’s REDEFINE 4 Trial: What Its Findings Signal for Obesity Treatment Constraints
Impact of CagriSema’s Trial Results Novo Nordisk’s CagriSema has faced a significant setback by failing to meet its primary endpoint…
“How Onion Powder Challenges Conventional Weight Loss and Health Beliefs”
Understanding Onion Powder’s Role in Weight Loss and PCOS Onion powder is gaining attention for its potential benefits in weight…